New Amsterdam Partnersny Lowers stake in Varian Medical Systems (VAR)

Varian Medical Systems (VAR) : New Amsterdam Partnersny reduced its stake in Varian Medical Systems by 67.23% during the most recent quarter end. The investment management company now holds a total of 68,384 shares of Varian Medical Systems which is valued at $6,472,546 after selling 140,264 shares in Varian Medical Systems , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Varian Medical Systems makes up approximately 1.50% of New Amsterdam Partnersny’s portfolio.

Other Hedge Funds, Including , South Texas Money Management Ltd boosted its stake in VAR in the latest quarter, The investment management firm added 7,597 additional shares and now holds a total of 305,803 shares of Varian Medical Systems which is valued at $28,944,254. Varian Medical Systems makes up approx 1.57% of South Texas Money Management Ltd’s portfolio.Meeder Asset Management Inc boosted its stake in VAR in the latest quarter, The investment management firm added 266 additional shares and now holds a total of 6,991 shares of Varian Medical Systems which is valued at $608,497. Varian Medical Systems makes up approx 0.06% of Meeder Asset Management Inc’s portfolio. Curian Capital sold out all of its stake in VAR during the most recent quarter. The investment firm sold 47,125 shares of VAR which is valued $4,005,154.

Varian Medical Systems opened for trading at $94.63 and hit $95.21 on the upside on Thursday, eventually ending the session at $94.82, with a gain of 0.18% or 0.17 points. The heightened volatility saw the trading volume jump to 6,48,019 shares. Company has a market cap of $9,028 M.

On the company’s financial health, Varian Medical Systems reported $1.22 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $1.17. The company had revenue of $789.40 million for the quarter, compared to analysts expectations of $782.00 million. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS.

Many Wall Street Analysts have commented on Varian Medical Systems. Company shares were Reiterated by Barrington Research on Jul 28, 2016 to “Outperform”, Firm has raised the Price Target to $ 102 from a previous price target of $93 .

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy radiosurgery proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical scientific and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer taking X-ray images and protecting ports and borders. The Company’s products include linear accelerators brachytherapy afterloaders treatment simulation and verification equipment accessories information management treatment planning and image processing software. The Company’s customers include university research and community hospitals private and governmental institutions healthcare agencies doctors’ offices and cancer care clinics.

Leave a Reply

Varian Medical Systems - Is it time to Sell?

Top Brokerage Firms are advising their investors on Varian Medical Systems. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.